Craig B. Thompson

Insider Reports History

Location
2000 Galloping Hill Road, Kenilworth, NJ
Signature
/s/ Craig B. Thompson, M.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Craig B. Thompson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. Director Common Stock 620 $439K $708.19 Jan 2, 2025 Direct
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director Common Stock 2.41K $326K $134.98 May 21, 2025 Direct
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director Stock Options (Right to Buy) 2.08K $280K $134.98 May 21, 2025 Direct
REGENERON PHARMACEUTICALS, INC. Director Non-Qualified Stock Option (right to buy) 1.96K Jan 2, 2025 Direct

Insider Reports Filed by Craig B. Thompson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. May 21, 2025 2 $408K 4 May 23, 2025 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 2, 2025 2 $0 4 Jan 6, 2025 Director
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. May 13, 2024 2 $427K 4 May 15, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 2, 2024 2 $0 4 Jan 4, 2024 Director
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. May 15, 2023 2 $321K 4 May 17, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 3, 2023 2 $0 4 Jan 5, 2023 Director
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Jan 3, 2023 2 $129K 4 Jan 4, 2023 Director
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Dec 5, 2022 0 $0 3 Dec 14, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Oct 3, 2022 2 $0 4 Oct 5, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Oct 3, 2022 0 $0 3 Oct 5, 2022 Director